Massimo Montano

Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild‐type <scp><i>KRAS</i></scp> advanced biliary tract cancer: A randomized phase 2 trial (<scp>V</scp>ecti‐<scp>BIL</scp> study)

Francesco Leone, Donatella Marino, Stefano Cereda et al. · Cancer · 2015 · 140 citations · Full text

Medicine, Oncology, Pharmacology +13

Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer

Emilio Bajetta, Irene Floriani, Maria Di Bartolomeo et al. · Annals of Oncology · 2014 · 90 citations · Full text

Medicine, Oncology, Chemotherapy +10

Phase II clinical study of valproic acid plus cisplatin and cetuximab in recurrent and/or metastatic squamous cell carcinoma of Head and Neck-V-CHANCE trial

Francesco Caponigro, Elena Di Gennaro, Franco Ionna et al. · BMC Cancer · 2016 · 79 citations · Full text

Medicine, Oncology, Pharmacology +15

Early FDG PET response assessment of preoperative radiochemotherapy in locally advanced rectal cancer: correlation with long-term outcome

Antonio Avallone, Luigi Aloj, Corradina Caracò et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2012 · 61 citations

Medicine, Nuclear Medicine, Oncology +17

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)

Antonio Avallone, Maria Carmela Piccirillo, Paolo Delrio et al. · BMC Cancer · 2014 · 41 citations · Full text

Medicine, Oncology, Radiation Oncology +16